277 related articles for article (PubMed ID: 18662240)
1. Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging.
Larsen SG; Wiig JN; Emblemsvaag HL; Grøholt KK; Hole KH; Bentsen A; Dueland S; Vetrhus T; Giercksky KE
Colorectal Dis; 2009 Sep; 11(7):759-67. PubMed ID: 18662240
[TBL] [Abstract][Full Text] [Related]
2. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
3. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging.
Koh DM; Chau I; Tait D; Wotherspoon A; Cunningham D; Brown G
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):456-61. PubMed ID: 18164860
[TBL] [Abstract][Full Text] [Related]
4. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting anastomotic complications following anterior resection in rectal cancer.
Lyall A; Mc Adam TK; Townend J; Loudon MA
Colorectal Dis; 2007 Nov; 9(9):801-7. PubMed ID: 17931170
[TBL] [Abstract][Full Text] [Related]
6. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence.
Daniels IR; Fisher SE; Heald RJ; Moran BJ
Colorectal Dis; 2007 May; 9(4):290-301. PubMed ID: 17432979
[TBL] [Abstract][Full Text] [Related]
7. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
[TBL] [Abstract][Full Text] [Related]
8. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
9. Multimedia article. Laparoscopic ultralow anterior resection with colonic J-pouch-anal anastomosis.
Selvindos PB; Ho YH
Dis Colon Rectum; 2008 Nov; 51(11):1710-1. PubMed ID: 18679748
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience.
Valentini V; Coco C; Rizzo G; Manno A; Crucitti A; Mattana C; Ratto C; Verbo A; Vecchio FM; Barbaro B; Gambacorta MA; Montoro C; Barba MC; Sofo L; Papa V; Menghi R; D'Ugo DM; Doglietto G
Surgery; 2009 May; 145(5):486-94. PubMed ID: 19375606
[TBL] [Abstract][Full Text] [Related]
11. Mesorectal grades predict recurrences after curative resection for rectal cancer.
Maslekar S; Sharma A; Macdonald A; Gunn J; Monson JR; Hartley JE
Dis Colon Rectum; 2007 Feb; 50(2):168-75. PubMed ID: 17160574
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging prediction of an involved surgical resection margin in low rectal cancer.
Salerno GV; Daniels IR; Moran BJ; Heald RJ; Thomas K; Brown G
Dis Colon Rectum; 2009 Apr; 52(4):632-9. PubMed ID: 19404067
[TBL] [Abstract][Full Text] [Related]
13. Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age.
Larsen SG; Wiig JN; Tretli S; Giercksky KE
Colorectal Dis; 2006 Mar; 8(3):177-85. PubMed ID: 16466556
[TBL] [Abstract][Full Text] [Related]
14. Effects of radiotherapy on different histopathological types of rectal carcinoma.
Sengul N; Wexner SD; Woodhouse S; Arrigain S; Xu M; Larach JA; Ahn BK; Weiss EG; Nogueras JJ; Berho M
Colorectal Dis; 2006 May; 8(4):283-8. PubMed ID: 16630231
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.
Patel UB; Taylor F; Blomqvist L; George C; Evans H; Tekkis P; Quirke P; Sebag-Montefiore D; Moran B; Heald R; Guthrie A; Bees N; Swift I; Pennert K; Brown G
J Clin Oncol; 2011 Oct; 29(28):3753-60. PubMed ID: 21876084
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status.
Kulkarni T; Gollins S; Maw A; Hobson P; Byrne R; Widdowson D
Colorectal Dis; 2008 Jun; 10(5):479-89. PubMed ID: 18318754
[TBL] [Abstract][Full Text] [Related]
17. Combined-modality therapy with sphincter-preserving total mesorectal excision for locally advanced rectal cancer: patient's age and long-term outcome.
Szynglarewicz B; Matkowski R; Maciejczyk A; Kasprzak P; Forgacz J; Pudelko M
J Gastrointestin Liver Dis; 2008 Mar; 17(1):49-52. PubMed ID: 18392244
[TBL] [Abstract][Full Text] [Related]
18. Preoperative staging of rectal cancer.
Smith N; Brown G
Acta Oncol; 2008; 47(1):20-31. PubMed ID: 17957502
[TBL] [Abstract][Full Text] [Related]
19. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.
den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ
Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
